Shattuck Labs, Inc.
STTK · XNASCIK 1680367fmd_1VSC1X09TBJB4KFS6C555Z8QFGManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2019 to Sep 30, 2026, 31 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Total revenues | 10 | 10 | 30 | 1 | 2 | 6 | 1 |
| Research and development | 29 | 37 | 57 | 83 | 74 | 67 | 35 |
| Total operating expenses | 35 | 47 | 75 | 104 | 94 | 86 | 53 |
| Operating income | (25) | (37) | (45) | (103) | (92) | (81) | (52) |
| Interest and investment income | 1 | 1 | 1 | 2 | 5 | 5 | 3 |
| Other non-operating income (expense) | 1 | 0 | 0 | 1 | 5 | 5 | 3 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | (24) | (37) | (45) | (102) | (87) | (75) | (49) |